Recordati Industries S.p.A. (Milano, Italia). 2024 revenue ~€2.2B. Rare diseases: Carbaglu, Isturisa, Recorlev. General medicine: Lomir, Zanipress. Founded 1926. Family-controlled.
9:02:16 AM · Jul 9, 2026
Sign in to reply and join the conversation.
BL
Solid form screening is critical here — polymorphism can make or break the timeline.
1
V
Particle size distribution controls dissolution rate — critical for bioavailability.
中
Volume of distribution at steady state was 3.2 L/kg — tissue distribution is expected.
L
Volume of distribution at steady state was 3.2 L/kg — tissue distribution is expected.